(OTC: BMGP) New Chinese acquisitions - Penny Stocks

ActionCapitalGp · Tue, 03-11-2008, 09:09 AM

March 3 - Biomagnetics Technological Review

Biomagnetics Diagnostics Corporation (OTC:BMGP), a statement from the president of Biomagnetics Diagnostics Corp., Clayton M. Hardman. Broadening our product line and opening up more markets.

Our approach to expanding the market is simple; add additional assays and enter additional markets (countries).

The Company has also applied for a patent, for a new diagnostic system designed for multi-analyte testing for blood banks titled “SYSTEM AND METHOD FOR DETECTING SPECIFIC BINDING REACTIONS USING MAGNETIC LABELS.” This technology uses a combination of opposing magnetic fields and light refraction.

Blood banks receive and test approximately 14 million units of blood annually. Each unit is tested for 9 infectious diseases totaling 126 million diagnostics tests. We hope to bring this new system to market in 2009. The costs of performing these diagnostics including assays, staffing and general overhead which exceeds all revenues. Our system will perform all 9 required tests in a single assay, thus substantially reducing the costs blood banks will incur.

Generally speaking all blood banks operate in the red. We believe our new system will save 30 to 40 percent on blood diagnostics and turn their red into black overnight.

stockwhiz85 · Tue, 03-11-2008, 10:54 AM

let me add BMGP's latest pr, worth checking out!!

Biomagnetics Diagnostics Corporation, through its wholly owned subsidiary Biospectrum Technologies, Inc., a company that has designed and patented revolutionary diagnostic equipment and immunoassays, will identify market inadequacies and fill those needs with new technologies and highly specific and sensitive assays that are qualitative (yes/no) and quantitative (viral load/degree of infection), easily performed and cost effective.

LATEST PR 3/10 - Current Project for Biomagnetics Diagnostics Corp.

ORANGEVALE, Calif., Mar 10, 2008 (BUSINESS WIRE) -- Biomagnetics Diagnostics Corporation announced today that is continuing formal negotiations to purchase an interest in Tianjin Automatic Science & Instrument Co. LTD.
1) Auto Science is located in Tianjin, China's third largest city with a population of 9.5 million. Tianjin is a major comprehensive industrial base in northern China. It has over 150 lines of industry consisting primarily of electronics, automobile, metallurgy, pharmaceuticals, textiles, chemicals and mechanics.
Tianjin Auto Science has been in business over 15 years. By acquiring an interest in Tianjin Auto Science, Biomagnetics Diagnostics will gain access to over 1,250 distributors, a laboratory client base of 10,000 and skilled manufacturing in the business community's most exciting markets.
2) We have received quotes to manufacturing our Assays from Shanghai Jing Ying Biotechnology Co. and are now conducting due diligence.
3) Biomagnetics has entered into a memorandum of understanding whereby B.R.I.A. will undertake the responsibility to represent Biomagnetics Diagnostics Corp. in acquiring the required Health Ministry approvals to perform clinical trials in Thailand on the HTS-MTP Diagnostic System, including the Company's proprietary HIV and Hepatitis B assays.
(BRIA is a leading company in healthcare service for over 25 years. They provide clinical lab services and distribute the rapid IVD test kits to hospitals and clinics in this region. Their business includes; Clinical laboratory service for hospitals, clinics and CROs.)

For more information please visit: Welcome to Biomagnetics Diagnostics Corporation.

Forward-looking Statement:
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events of future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluation such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company's SEC filings. These risks and uncertainties could cause the company's actual results to differ materially from those indicated in the forward-looking statements.

SOURCE: Biomagnetics Diagnostics Corporation

bullpicks6 · Tue, 03-11-2008, 11:30 AM

the news yesterday, leads me to believe we'll be seeing nice results from this company in the near future, based on the addition of new distribution channels and a client base, i'd expect to see some revenue, should be a good entry here on the stock

stockwhiz85 · Tue, 03-11-2008, 06:46 PM

well, according to my crystal ball, BMGP is heading for a big week

stockwhiz85 · Wed, 03-12-2008, 05:54 PM

BMGP'S HTS-MTP system performs the screening, confirmatory and viral load test in a single function for the single cost of $2.50 - this would translate into huge savings in healthcare by narrowing down the three step diagnostic process (screening, confirmatory, viral load testing) into a single effective and cost-efficient test.

Tue, 03-11-2008, 09:09 AM	#1 (permalink)
ActionCapitalGp Super Moderator Join Date: Feb 2006 Posts: 139	(OTC: BMGP) New Chinese acquisitions March 3 - Biomagnetics Technological Review Biomagnetics Diagnostics Corporation (OTC:BMGP), a statement from the president of Biomagnetics Diagnostics Corp., Clayton M. Hardman. Broadening our product line and opening up more markets. Our approach to expanding the market is simple; add additional assays and enter additional markets (countries). The Company has also applied for a patent, for a new diagnostic system designed for multi-analyte testing for blood banks titled “SYSTEM AND METHOD FOR DETECTING SPECIFIC BINDING REACTIONS USING MAGNETIC LABELS.” This technology uses a combination of opposing magnetic fields and light refraction. Blood banks receive and test approximately 14 million units of blood annually. Each unit is tested for 9 infectious diseases totaling 126 million diagnostics tests. We hope to bring this new system to market in 2009. The costs of performing these diagnostics including assays, staffing and general overhead which exceeds all revenues. Our system will perform all 9 required tests in a single assay, thus substantially reducing the costs blood banks will incur. Generally speaking all blood banks operate in the red. We believe our new system will save 30 to 40 percent on blood diagnostics and turn their red into black overnight. __________________ Information brought to you courtesy of ActionCapitalGroupe.com Sebastien Durand La Centrale Small Caps en Francais Action Capital Groupe

Tue, 03-11-2008, 10:54 AM	#2 (permalink)
stockwhiz85 Super Moderator Join Date: Jan 2007 Posts: 238	BMGP's latest PR let me add BMGP's latest pr, worth checking out!! Biomagnetics Diagnostics Corporation, through its wholly owned subsidiary Biospectrum Technologies, Inc., a company that has designed and patented revolutionary diagnostic equipment and immunoassays, will identify market inadequacies and fill those needs with new technologies and highly specific and sensitive assays that are qualitative (yes/no) and quantitative (viral load/degree of infection), easily performed and cost effective. LATEST PR 3/10 - Current Project for Biomagnetics Diagnostics Corp. ORANGEVALE, Calif., Mar 10, 2008 (BUSINESS WIRE) -- Biomagnetics Diagnostics Corporation announced today that is continuing formal negotiations to purchase an interest in Tianjin Automatic Science & Instrument Co. LTD. 1) Auto Science is located in Tianjin, China's third largest city with a population of 9.5 million. Tianjin is a major comprehensive industrial base in northern China. It has over 150 lines of industry consisting primarily of electronics, automobile, metallurgy, pharmaceuticals, textiles, chemicals and mechanics. Tianjin Auto Science has been in business over 15 years. By acquiring an interest in Tianjin Auto Science, Biomagnetics Diagnostics will gain access to over 1,250 distributors, a laboratory client base of 10,000 and skilled manufacturing in the business community's most exciting markets. 2) We have received quotes to manufacturing our Assays from Shanghai Jing Ying Biotechnology Co. and are now conducting due diligence. 3) Biomagnetics has entered into a memorandum of understanding whereby B.R.I.A. will undertake the responsibility to represent Biomagnetics Diagnostics Corp. in acquiring the required Health Ministry approvals to perform clinical trials in Thailand on the HTS-MTP Diagnostic System, including the Company's proprietary HIV and Hepatitis B assays. (BRIA is a leading company in healthcare service for over 25 years. They provide clinical lab services and distribute the rapid IVD test kits to hospitals and clinics in this region. Their business includes; Clinical laboratory service for hospitals, clinics and CROs.) For more information please visit: Welcome to Biomagnetics Diagnostics Corporation. Forward-looking Statement: This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events of future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluation such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company's SEC filings. These risks and uncertainties could cause the company's actual results to differ materially from those indicated in the forward-looking statements. SOURCE: Biomagnetics Diagnostics Corporation

Tue, 03-11-2008, 11:30 AM	#3 (permalink)
bullpicks6 Member Join Date: Mar 2007 Posts: 21	looks interesting, nice news yesterday the news yesterday, leads me to believe we'll be seeing nice results from this company in the near future, based on the addition of new distribution channels and a client base, i'd expect to see some revenue, should be a good entry here on the stock

Tue, 03-11-2008, 06:46 PM	#4 (permalink)
stockwhiz85 Super Moderator Join Date: Jan 2007 Posts: 238	yeah..I can feel it...something nice well, according to my crystal ball, BMGP is heading for a big week

Wed, 03-12-2008, 05:54 PM	#5 (permalink)
stockwhiz85 Super Moderator Join Date: Jan 2007 Posts: 238	BMGP - Revolutionizing In-Vitro Testing technology BMGP'S HTS-MTP system performs the screening, confirmatory and viral load test in a single function for the single cost of $2.50 - this would translate into huge savings in healthcare by narrowing down the three step diagnostic process (screening, confirmatory, viral load testing) into a single effective and cost-efficient test. Last edited by stockwhiz85 : Wed, 03-12-2008 at 06:19 PM.

Thread Tools	Search this Thread
Show Printable Version Email this Page	Search this Thread: Advanced Search
Display Modes
Linear Mode Switch to Hybrid Mode Switch to Threaded Mode